Key result
This review discusses the indications, utilization trends, procedural planning, and clinical outcomes of transcatheter mitral valve replacement for valve-in-valve, valve-in-ring, and valve-in-MAC.
Why the study?
Experience over the past decade with TMVR has identified important challenges and solutions to improve clinical outcomes.
TMVR is an increasingly utilized alternative for failed bioprosthetic valves, rings, and severe MAC, though valve-in-MAC procedures remain associated with high mortality and require meticulous preprocedural planning to prevent complications like LVOT obstruction.
May inform TMVR planning for failed mitral valves; leaves open optimal strategies to reduce valve-in-MAC mortality.
Transcatheter mitral valve replacement (TMVR) using the SAPIEN platform has been performed in failed bioprosthetic valves (valve-in-valve), surgical annuloplasty rings (valve-in-ring), and native valves with mitral annular calcification (MAC) (valve-in-MAC). Experience over the past decade has identified important challenges and solutions to improve clinical outcomes. In this review, we discuss the indication, trend in utilization, unique challenges, procedural planning, and clinical outcomes of valve-in-valve, valve-in-ring, and valve-in-MAC TMVR.
No takes yet. Share an insight, caveat, or question.
Ueyama et al. (2023) conducted a review in Mitral valve disease (failed bioprosthetic valve, ring, and mitral annular calcification). Transcatheter mitral valve replacement (TMVR) using the SAPIEN platform was evaluated. This review discusses the indications, utilization trends, procedural planning, and clinical outcomes of transcatheter mitral valve replacement for valve-in-valve, valve-in-ring, and valve-in-MAC.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: